These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8942750)

  • 1. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension.
    Stanley AJ; Gilmour HM; Ghosh S; Ferguson A; McGilchrist AJ
    Gastroenterology; 1996 Dec; 111(6):1679-82. PubMed ID: 8942750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is protein-losing enteropathy a significant complication of portal hypertension?
    Conn HO
    Am J Gastroenterol; 1998 Jan; 93(1):127-8. PubMed ID: 9448196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
    Carrillo-Esper R; Carrillo-Cortes U; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA; Carrillo-Córdova DM
    Cir Cir; 2013; 81(2):143-7. PubMed ID: 23522316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.
    Saugel B; Mair S; Meidert AS; Phillip V; Messer M; Nennstiel S; Berger H; Gaa J; Wagner JY; Schneider H; Schmid RM; Huber W
    J Crit Care; 2014 Dec; 29(6):1001-5. PubMed ID: 25220530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
    Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
    Riggio O; Ridola L; Lucidi C; Angeloni S
    Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].
    Zhao JB; Ye P; Zeng QL; Pang HJ; He XF; Chen Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):294-6. PubMed ID: 26922035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiodermatitis after transjugular intrahepatic portosystemic shunt: 4 cases].
    Fierens H; Goffette P; Tennstedt D; Lachapelle J
    Ann Dermatol Venereol; 2000; 127(6-7):619-23. PubMed ID: 10930861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Portal vein thrombosis after occlusion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS). Shunt dilatation with subsequent local and systemic thrombolysis].
    Gabler R; Barnert J; Bohndorf K; Eberl T; Wienbeck M
    Dtsch Med Wochenschr; 1997 Feb; 122(7):188-92. PubMed ID: 9072489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic assessment of spleen stiffness before and after transjugular intrahepatic portosystemic shunt placement with or without concurrent embolization of portal systemic collateral veins in patients with cirrhosis and portal hypertension: a feasibility study.
    Novelli PM; Cho K; Rubin JM
    J Ultrasound Med; 2015 Mar; 34(3):443-9. PubMed ID: 25715365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension.
    Fleet M; Stanley AJ; Forrest EH; Hayes PC; Redhead DN
    Clin Radiol; 2000 Mar; 55(3):236-7. PubMed ID: 10708619
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
    Therapondos G; Wong F
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device.
    Lauermann J; Potthoff A; Mc Cavert M; Marquardt S; Vaske B; Rosenthal H; von Hahn T; Wacker F; Meyer BC; Rodt T
    Cardiovasc Intervent Radiol; 2016 Apr; 39(4):547-56. PubMed ID: 26404629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage.
    McAvoy NC; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1135-41. PubMed ID: 17033431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.
    Luo SH; Chu JG; Huang H; Yao KC
    World J Gastroenterol; 2017 Jul; 23(26):4779-4787. PubMed ID: 28765699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.